Literature DB >> 25449242

Healthcare-associated respiratory tract infection and colonization in an intensive care unit caused by Burkholderia cepacia isolated in mouthwash.

Jeannete Zurita1, Lorena Mejia2, Sonia Zapata2, Gabriel Trueba2, Ana Cecilia Vargas3, Samanta Aguirre4, Guillermo Falconi4.   

Abstract

OBJECTIVES: Burkholderia cepacia has been linked to healthcare-associated infections and colonization caused by contamination of alcohol-free mouthwash used in patients undergoing mechanical ventilation. The purpose of our study was to establish the source of a clustering of healthcare-associated B. cepacia isolates in patients on mechanical ventilation in the intensive care unit (ICU).
METHODS: During April 2012 the Infection Control Committee became concerned when B. cepacia was isolated from tracheal aspirate cultures of three ICU patients. The medical records for the years 2011 and 2012 were reviewed to identify further cases. Cultures of potential reservoirs were done. Isolates from patients and an alcohol-free mouthwash were submitted to multilocus sequence typing (MLST) analysis and antimicrobial resistance testing.
RESULTS: Four patients with positive cultures for B. cepacia were identified before the review of the medical records for the years 2011 and 2012. Nine further cases were identified in the review, defined as a patient with pneumonia who had a culture of respiratory secretions that was positive for B. cepacia. Three were cases of infection and 10 were colonizations. All of the isolates from patients (J, K, L, and M) and mouthwash samples (B19, B20, and B21) were genetically identical by MLST analysis.
CONCLUSIONS: Our findings strongly suggest that alcohol-free mouthwash solution intrinsically contaminated with B. cepacia was the source of these colonizations and infections involving adults in the ICU.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Burkholderia cepacia; Healthcare-associated infections; ICU; Mouthwash; Outbreak

Mesh:

Substances:

Year:  2014        PMID: 25449242     DOI: 10.1016/j.ijid.2014.07.016

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  6 in total

Review 1.  Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products.

Authors:  Mariana Tavares; Mariya Kozak; Alexandra Balola; Isabel Sá-Correia
Journal:  Clin Microbiol Rev       Date:  2020-04-15       Impact factor: 26.132

2.  Combined Clinical, Epidemiological, and Genome-Based Analysis Identified a Nationwide Outbreak of Burkholderia cepacia Complex Infections Caused by Contaminated Mouthwash Solutions.

Authors:  Jennifer K Bender; Sebastian Haller; Yvonne Pfeifer; Michael Hogardt; Klaus-Peter Hunfeld; Andrea Thürmer; Arina Zanuzdana; Markus Werner; Bernd Kunz; David Eisenberger; Niels Pfennigwerth; Volkhard A J Kempf; Guido Werner; Tim Eckmanns
Journal:  Open Forum Infect Dis       Date:  2022-03-09       Impact factor: 3.835

3.  Cepacia Syndrome in a Non-Cystic Fibrosis Patient.

Authors:  Naomi Hauser; Jose Orsini
Journal:  Case Rep Infect Dis       Date:  2015-08-18

4.  Burkholderia contaminans Colonization from Contaminated Liquid Docusate (Colace) in a Immunocompetent Adult with Legionnaire's Disease: Infection Control Implications and the Potential Role of Candida pellucosa.

Authors:  Burke A Cunha; John Gian; Bertamaria Dieguez; Elsa Santos-Cruz; Daniela Matassa; Steve Gerson; Pat Daniels; Carlos Rosales; Rodger P Silletti
Journal:  J Clin Med       Date:  2016-11-30       Impact factor: 4.241

5.  Emergence of Burkholderia cepacia in ICU Setting.

Authors:  Suneeta Meena; Raunak Bir; Seema Sood; Bimal Kumar Das; Arti Kapil
Journal:  Indian J Crit Care Med       Date:  2019-09

6.  Burkholderia cepacia Complex Taxon K: Where to Split?

Authors:  Eliza Depoorter; Evelien De Canck; Charlotte Peeters; Anneleen D Wieme; Margo Cnockaert; James E A Zlosnik; John J LiPuma; Tom Coenye; Peter Vandamme
Journal:  Front Microbiol       Date:  2020-07-14       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.